Sharps Logo.jpg
Sharps Technology Provides Update on Commercialization Activities and is Highlighted in Med Tech Outlook Feature Article
July 06, 2023 07:50 ET | Sharps Technology Inc
Company advances commercialization of Securegard smart safety syringe product linethrough qualification programs with a major medical device company Production of prefilled syringe products will...
Sharps Logo.jpg
Sharps Technology Issues Update Letter to Shareholders from CEO Robert Hayes
April 04, 2023 08:00 ET | Sharps Technology Inc
Commercial revenue from specialty safety syringe systems is advancing Company to launch its vial draw syringe systems in Q2 2023Launch of high-value, next-generation polymer-based products expected in...
Sharps Logo.jpg
Sharps Technology Appoints Justin Page as Vice President of Technical Operations
February 09, 2023 09:21 ET | Sharps Technology Inc
NEW YORK, Feb. 09, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”, "Sharps") (NASDAQ: “STSS” and “STSSW”), an innovative medical device and drug delivery Company offering patented,...
Sharps Logo.jpg
Sharps Technology Announces Closing of $3.8 Million Private Placement Priced At-the-Market
February 06, 2023 09:02 ET | Sharps Technology Inc
NEW YORK, Feb. 06, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”, "Sharps") (NASDAQ: “STSS” and “STSSW”), an innovative medical device and drug delivery Company offering patented,...
Sharps Logo.jpg
Sharps Technology Announces Pricing of $3.8 Million Private Placement Priced at the Market
February 01, 2023 09:20 ET | Sharps Technology Inc
NEW YORK, Feb. 01, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”, "Sharps") (NASDAQ: “STSS” and “STSSW”), an innovative medical device and drug delivery Company offering patented,...
Sharps Logo.jpg
Sharps Technology Ships First Containers of Safety Syringes to Nephron Pharmaceuticals for Commercialization
January 31, 2023 08:00 ET | Sharps Technology Inc
First product shipped from Sharps' facility in Hungary and first to support the Nephron Pharmaceuticals distribution and sales collaboration Sharps anticipates 1.3 million units to be...
Sharps Logo.jpg
Sharps Technology Inc. to Introduce New Specialized Prefillable Syringe Systems in 2023
January 10, 2023 08:00 ET | Sharps Technology Inc
High-Value specialized prefillable syringe systems to accelerate revenue growth in 2023 and beyond Company to launch next generation specialty polymer-based syringe products for the healthcare market...
Sharps Logo.jpg
Sharps Technology Begins Manufacturing at its Hungary Facility for the Company's Innovative Syringe Products
December 20, 2022 08:00 ET | Sharps Technology Inc
Company now transitions from a pre-revenue research & development start-up to a revenue generating manufacturing company Shipments to commence by the end of the year to support the recently...
Sharps Logo.jpg
Sharps Technology and Nephron Pharmaceuticals Sign Distribution Agreement for its Innovative Syringe Products
December 13, 2022 08:00 ET | Sharps Technology Inc
Company anticipates products to be available in the first quarter of 2023 with initial revenue from this agreement expected in the first half of the year Strengthens the collaboration between Sharps...
Sharps Logo.jpg
Nephron Pharmaceuticals Corporation and Sharps Technology, Inc. Announce Manufacturing and Research Partnership
November 10, 2022 16:05 ET | Sharps Technology Inc
WEST COLUMBIA, S.C. and NEW YORK, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Nephron Pharmaceuticals Corporation and Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), an innovative...